Literature DB >> 26757146

Neonatal Vaccination: Challenges and Intervention Strategies.

Matthew C Morris1, Naveen Surendran.   

Abstract

BACKGROUND: While vaccines have been tremendously successful in reducing the incidence of serious infectious diseases, newborns remain particularly vulnerable in the first few months of their life to life-threatening infections. A number of challenges exist to neonatal vaccination. However, recent advances in the understanding of neonatal immunology offer insights to overcome many of those challenges.
OBJECTIVE: This review will present an overview of the features of neonatal immunity which make vaccination difficult, survey the mechanisms of action of available vaccine adjuvants with respect to the unique features of neonatal immunity, and propose a possible mechanism contributing to the inability of neonates to generate protective immune responses to vaccines.
METHODS: We surveyed recent published findings on the challenges to neonatal vaccination and possible intervention strategies including the use of novel vaccine adjuvants to develop efficacious neonatal vaccines.
RESULTS: Challenges in the vaccination of neonates include interference from maternal antibody and excessive skewing towards Th2 immunity, which can be counteracted by the use of proper adjuvants.
CONCLUSION: Synergistic stimulation of multiple Toll-like receptors by incorporating well-defined agonist-adjuvant combinations to vaccines is a promising strategy to ensure a protective vaccine response in neonates.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26757146      PMCID: PMC4749499          DOI: 10.1159/000442460

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  75 in total

1.  Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.

Authors:  Doreen Krumbiegel; Fred Zepp; Claudius Ullrich Meyer
Journal:  Hum Immunol       Date:  2007-08-29       Impact factor: 2.850

Review 2.  Vaccine adjuvant formulations: a pharmaceutical perspective.

Authors:  Luis A Brito; Padma Malyala; Derek T O'Hagan
Journal:  Semin Immunol       Date:  2013-07-12       Impact factor: 11.130

3.  Staphylococcus aureus Adenosine Inhibits sPLA2-IIA-Mediated Host Killing in the Airways.

Authors:  Erwan Pernet; Jérémy Brunet; Laurent Guillemot; Michel Chignard; Lhousseine Touqui; Yongzheng Wu
Journal:  J Immunol       Date:  2015-04-22       Impact factor: 5.422

Review 4.  Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease.

Authors:  Trevor D Burt
Journal:  Am J Reprod Immunol       Date:  2013-02-25       Impact factor: 3.886

5.  Neonatal antigen-presenting cells are functionally more quiescent in children born under traditional compared with modern environmental conditions.

Authors:  Joanne G Lisciandro; Susan L Prescott; Marie G Nadal-Sims; Catherine J Devitt; Peter C Richmond; William Pomat; Peter M Siba; Patrick G Holt; Deborah H Strickland; Anita H J van den Biggelaar
Journal:  J Allergy Clin Immunol       Date:  2012-07-19       Impact factor: 10.793

6.  Safety of vaccine adjuvants: focus on autoimmunity.

Authors:  Jan Willem van der Laan; Sarah Gould; Jennifer Y Tanir
Journal:  Vaccine       Date:  2015-02-07       Impact factor: 3.641

7.  The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model.

Authors:  Elizabeth B Norton; David L Bauer; William C Weldon; M Steven Oberste; Louise B Lawson; John D Clements
Journal:  Vaccine       Date:  2015-03-09       Impact factor: 3.641

8.  Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.

Authors:  Monika Polewicz; Aleksandra Gracia; Srinivas Garlapati; Jill van Kessel; Stacy Strom; Scott A Halperin; Robert E W Hancock; Andrew A Potter; Lorne A Babiuk; Volker Gerdts
Journal:  Vaccine       Date:  2013-05-15       Impact factor: 3.641

9.  The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling.

Authors:  Christopher James Ferrante; Grace Pinhal-Enfield; Genie Elson; Bruce Neil Cronstein; Gyorgy Hasko; Shalini Outram; Samuel Joseph Leibovich
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

10.  Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys.

Authors:  Sallie R Permar; Sherry A Klumpp; Keith G Mansfield; Woong-Ki Kim; Darci A Gorgone; Michelle A Lifton; Kenneth C Williams; Jörn E Schmitz; Keith A Reimann; Michael K Axthelm; Fernando P Polack; Diane E Griffin; Norman L Letvin
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more
  12 in total

1.  Specialized Proresolving Mediators Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Reinfection.

Authors:  Luis Alonso Diaz; Norman H Altman; Wasif N Khan; Charles N Serhan; Becky Adkins
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 2.  Vaccine responses in newborns.

Authors:  Anja Saso; Beate Kampmann
Journal:  Semin Immunopathol       Date:  2017-11-09       Impact factor: 9.623

Review 3.  Neonatal vaccine effectiveness and the role of adjuvants.

Authors:  Isaac G Sakala; Katherine Marie Eichinger; Nikolai Petrovsky
Journal:  Expert Rev Clin Immunol       Date:  2019-07-25       Impact factor: 4.473

4.  Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life.

Authors:  Pablo Martin Aispuro; Nicolás Ambrosis; María Eugenia Zurita; María Emilia Gaillard; Daniela Bottero; Daniela Flavia Hozbor
Journal:  Front Microbiol       Date:  2020-04-17       Impact factor: 5.640

5.  TLR agonist combinations that stimulate Th type I polarizing responses from human neonates.

Authors:  Naveen Surendran; Andrea Simmons; Michael E Pichichero
Journal:  Innate Immun       Date:  2018-04-19       Impact factor: 2.680

Review 6.  The historical aspects of vaccination in pregnancy.

Authors:  David William Mackin; Susan P Walker
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-10-13       Impact factor: 5.237

7.  Cyclic Di-Adenosine Monophosphate: A Promising Adjuvant Candidate for the Development of Neonatal Vaccines.

Authors:  Darío Lirussi; Sebastian Felix Weissmann; Thomas Ebensen; Ursula Nitsche-Gloy; Heiko B G Franz; Carlos A Guzmán
Journal:  Pharmaceutics       Date:  2021-02-01       Impact factor: 6.321

8.  A Model to Explain How the Bacille Calmette Guérin (BCG) Vaccine Drives Interleukin-12 Production in Neonates.

Authors:  Chido Loveness Kativhu; Daniel H Libraty
Journal:  PLoS One       Date:  2016-08-29       Impact factor: 3.240

9.  Transcriptome analysis of immune genes in peripheral blood mononuclear cells of young foals and adult horses.

Authors:  Rebecca L Tallmadge; Minghui Wang; Qi Sun; Maria Julia B Felippe
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

10.  The CTA1-DD adjuvant strongly potentiates follicular dendritic cell function and germinal center formation, which results in improved neonatal immunization.

Authors:  Sophie Schussek; Valentina Bernasconi; Johan Mattsson; Ulf Alexander Wenzel; Anneli Strömberg; Inta Gribonika; Karin Schön; Nils Y Lycke
Journal:  Mucosal Immunol       Date:  2020-01-20       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.